1. Home
  2. NPKI vs SYRE Comparison

NPKI vs SYRE Comparison

Compare NPKI & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NPKI
  • SYRE
  • Stock Information
  • Founded
  • NPKI 1932
  • SYRE 2013
  • Country
  • NPKI United States
  • SYRE United States
  • Employees
  • NPKI N/A
  • SYRE N/A
  • Industry
  • NPKI Metal Fabrications
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • NPKI Industrials
  • SYRE Health Care
  • Exchange
  • NPKI Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • NPKI 1.1B
  • SYRE 1.1B
  • IPO Year
  • NPKI N/A
  • SYRE 2016
  • Fundamental
  • Price
  • NPKI $12.76
  • SYRE $23.29
  • Analyst Decision
  • NPKI Strong Buy
  • SYRE Strong Buy
  • Analyst Count
  • NPKI 3
  • SYRE 5
  • Target Price
  • NPKI $14.17
  • SYRE $55.75
  • AVG Volume (30 Days)
  • NPKI 952.2K
  • SYRE 976.2K
  • Earning Date
  • NPKI 10-30-2025
  • SYRE 11-04-2025
  • Dividend Yield
  • NPKI N/A
  • SYRE N/A
  • EPS Growth
  • NPKI N/A
  • SYRE N/A
  • EPS
  • NPKI 0.38
  • SYRE N/A
  • Revenue
  • NPKI $259,372,000.00
  • SYRE N/A
  • Revenue This Year
  • NPKI $21.14
  • SYRE N/A
  • Revenue Next Year
  • NPKI $9.42
  • SYRE N/A
  • P/E Ratio
  • NPKI $33.62
  • SYRE N/A
  • Revenue Growth
  • NPKI 25.65
  • SYRE N/A
  • 52 Week Low
  • NPKI $4.76
  • SYRE $10.91
  • 52 Week High
  • NPKI $14.00
  • SYRE $40.26
  • Technical
  • Relative Strength Index (RSI)
  • NPKI 56.73
  • SYRE 59.48
  • Support Level
  • NPKI $12.12
  • SYRE $21.63
  • Resistance Level
  • NPKI $12.87
  • SYRE $25.06
  • Average True Range (ATR)
  • NPKI 0.58
  • SYRE 1.25
  • MACD
  • NPKI -0.09
  • SYRE -0.31
  • Stochastic Oscillator
  • NPKI 38.33
  • SYRE 55.12

About NPKI NPK International Inc. Common Stock

NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: